Related Experiment Video
Updated: May 12, 2026

10:15
A Preclinical Model to Assess Brain Recovery After Acute Stroke in Rats
Published on: November 6, 2019
Auditory Stimulation of Slow-Wave Sleep Promotes Recovery after Brain Injury in an Animal Model.
Carlos G Moreira1,2, Adrian Müllner1, Meltem Gönel1,3
1Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Annals of Neurology
|May 11, 2026
Summary
Closed-loop auditory stimulation (CLAS) enhances slow-wave activity, reducing brain injury and cognitive deficits in rats after traumatic brain injury (TBI). This sleep-based therapy shows promise for TBI survivors.
Area of Science:
- Neuroscience
- Sleep Science
- Traumatic Brain Injury Research
Background:
- Traumatic brain injury (TBI) causes significant long-term disability, with limited therapeutic options.
- Slow-wave activity during sleep is crucial for recovery but difficult to target pharmacologically.
- Existing methods to enhance slow-wave activity lack specificity and clinical translatability.
Purpose of the Study:
- To develop and evaluate a closed-loop auditory stimulation (CLAS) paradigm for targeted enhancement of slow-wave activity.
- To assess the efficacy of CLAS in mitigating TBI-induced brain damage and cognitive impairments in a preclinical model.
- To establish slow-wave activity enhancement as a potential therapeutic strategy for TBI.
Main Methods:
- A closed-loop auditory stimulation (CLAS) system delivered precise sound triggers during specific sleep phases in TBI and control rats.
- Two groups were studied: TBI rats receiving up-phase CLAS (upCLAS) and TBI rats receiving mock stimulation (mockCLAS).
- Histopathological assessments (axonal injury, demyelination, microglial response) and cognitive tests (novel object recognition) were performed.
Main Results:
- CLAS significantly reduced diffuse axonal injury and demyelination in TBI rats compared to mockCLAS.
- Cognitive deficits were observed in mockCLAS TBI rats, while upCLAS TBI rats performed significantly above chance, similar to controls.
- Enhanced slow-wave activity via CLAS modulated microglial response, reducing area coverage of Iba1+ cells.
Conclusions:
- CLAS is a viable preclinical approach to specifically enhance slow-wave activity.
- Boosted sleep intensity through CLAS demonstrates robust disease modification, reducing histopathological and cognitive sequelae of TBI.
- This sleep-based therapy offers a novel, nonobtrusive therapeutic avenue for TBI survivors.
